Immunology
Our immunology research spans the gamut from basic molecular studies through to clinical trials and new patient treatments.
We are particularly strong in the areas of conventional and unconventional T-cell immunity, cancer immunotherapy, autoimmune disease, homing and trafficking of immune cells and the structure biology of antigen receptors and the ligands they recognise.
Theme lead
Area of interest
T-cell ligands and the receptors that recognise them during infection, autoimmune disease, organ transplant and cancer immunotherapy.
Principal members of staff
| Name | Area of interest |
|---|---|
| Dr Pierre Rizkallah | Protein structure biology |
| Professor Colin Dayan | Autoimmune disease |
| Professor Susan Wong | Type 1 diabetes |
| Professor Bernhard Moser | Immune cell migration |
| Professor Andrew Godkin | MHC class II and cancer immunotherapy |
| Professor Awen Gallimore | Immune tolerance and cancer immunotherapy |
| Professor Matthias Eberl | Unconventional T-cells |
| Professor Ann Ager | Lymphocyte homing |
Research Groups
Our research creates benefits across health, society and the economy.
